treatment
Last reviewed 01/2018
- treatment of diastolic heart failure (DHF) (heart failure with preserved
left ventricular systolic ejection fraction (HFPEF)) is unsatisfactory
- systolic hypertension should be treated to achieve adequate blood pressure control (1)
- when fluid retention is present diuretics (frusemide or thiazide) have
been shown to improve symptoms (1)
- if the diagnosis has been made, patients can be started on low to medium dose of loop diuretics e.g. - less than 80mg of furosemide per day (2)
- coronary revascularisation should be considered if there is evidence of reversible myocardial ischaemia
- angiotensin converting enzyme inhibitors and angiotensin receptor blockers have been shown to improve symptoms and quality of life in patients with DHF, but do not reduce mortality (1)
- aldosterone antagonists reduce cardiac fibrosis and are also effective anti-hypertensives (1)
- advice on life-style and dietary changes given to patients with systolic heart failure (e.g. low salt intake) may also be helpful for patients with DHF
Notes:
- in the management of HFPEF treatment of comorbid conditions such as hypertension, myocardial ischemia and diabetes mellitus is thought to be important (2,3)
- patients who do not respond to loop diuretics should be referred to a specialist for further management (2).
- verapamil in HFPEF
- two very small studies with less than 30 patients in each have shown that verapamil is helpful in improving exercise capacity and symptoms in HFPEF patients (3)
Reference:
- 1) BHF Factfile 4/2010. Diastolic Heart Failure.
- 2) National Institute for Health and Clinical Excellence (NICE) 2010. Chronic heart failure. National clinical guideline for diagnosis and management in primary and secondary care
- 3) European Society of Cardiology (ESC) 2008. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008